Astrazeneca AZN
NYSE AZN
$160.15 +0.51 (+0.32%)
As of: Sep 11, 2026 · 3:59 PM EDT

Astrazeneca (AZN) EBIT Growth (3y) (2012 - 2026)

Analysis

Astrazeneca (AZN) EBIT Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Asml Holding 659.69 Bn 643.71 Bn 5.90 Bn -
2 General Electric 337.12 Bn 327.78 Bn 6.95 Bn 5.82%
3 Astrazeneca 247.89 Bn 242.60 Bn 12.86 Bn 8.81%
4 Citigroup 236.49 Bn -2,065.81 Bn 24.75 Bn -
5 Bhp 220.99 Bn 202.45 Bn - -
6 Rio Tinto 206.31 Bn 201.93 Bn - -
7 Diageo 192.64 Bn 190.61 Bn - -
8 National Grid 165.59 Bn 161.82 Bn - -
9 Unilever 135.28 Bn 128.25 Bn - -
10 Hdfc Bank 119.43 Bn 82.28 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.81%
Mar 31, 2026 18.54%
Dec 31, 2025 3.80%
Sep 30, 2025 42.24%
Jun 30, 2025 86.71%
Mar 31, 2025 61.14%
Dec 31, 2024 107.80%
Sep 30, 2024 48.25%
Jun 30, 2024 34.56%
Mar 31, 2024 18.02%
Dec 31, 2023 67.27%
Sep 30, 2023 18.61%
Jun 30, 2023 24.13%
Mar 31, 2023 27.84%
Dec 31, 2022 18.76%
Sep 30, 2022 18.04%
Jun 30, 2022 3.02%
Mar 31, 2022 -7.15%
Dec 31, 2021 -31.45%
Sep 30, 2021 -58.30%